Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms

• Published in: Letters in applied microbiology Vol. 69; no. 4; pp. 271 - 278
• Main Authors: Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Balázs, B., Majoros, L.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.10.2019
• Subjects: Aminoglycosides - pharmacology; Antifungal Agents - pharmacology; antifungal lock therapy; biofilm; Biofilms; Biofilms - growth & development; Candida; Candida albicans; Candida albicans - drug effects; Candida parapsilosis - drug effects; Caspofungin; Caspofungin - pharmacology; Catheter-Related Infections - drug therapy; Catheter-Related Infections - microbiology; Catheter-Related Infections - prevention & control; Cell death; Chitin; chitin synthase inhibitor; Correlation analysis; Drug Synergism; echinocandin; Echinocandins; Fluorescence; Fungicides; Humans; Medical instruments; Micafungin; Micafungin - pharmacology; Microbial Sensitivity Tests; Nikkomycin; resistance; Synergistic effect; Therapy; Viability; antifungal lock therapy; chitin synthase inhibitor; resistance; biofilm; echinocandin
• ISSN: 0266-8254; 1472-765X
• DOI: 10.1111/lam.13204

Antifungal lock therapy has received significant interest in the last few years because the frequently usage of intravascular devices is associated with an increasing number of catheter‐related bloodstream infections caused by Candida species. Antifungal combinations with synergistic interaction can be a good choice for antifungal lock therapy; therefore, interactions were examined between two echinocandins (caspofungin and micafungin) and the chitin synthesis inhibitor nikkomycin Z against Candida albicans and C. parapsilosis biofilms. Susceptibility was evaluated using the XTT‐based checkerboard microdilution method, while the nature of interactions was assessed by calculating fractional inhibitory concentration indices and using the Bliss independence model. Mathematic‐based evaluations were supplemented with fluorescent LIVE/DEAD viability assay. The results obtained by statistical interaction analyses correlated well with the viability assay. The tested echinocandins with nikkomycin Z caused an extended cell death and the structure of the biofilm was sparse compared to the control, especially for C. albicans. The findings support the simultaneous usage of nikkomycin Z and caspofungin or micafungin in alternative therapies such as the antifungal lock therapy. Significance and Impact of the Study Antifungal lock therapy can be a potential therapeutic approach to eradicate the intraluminal Candida biofilms; however, there is no approved lock strategy against fungal species so far. The results of this study provide valuable evidence that nikkomycin Z acts synergistically in combination with caspofungin or micafungin against biofilms. In addition, this synergy was more pronounced for micafungin combined with nikkomycin Z. Therefore, nikkomycin Z can be considered as a potential agent in antifungal lock therapy especially with micafungin against C. albicans or C. parapsilosis biofilms. Significance and Impact of the Study: Antifungal lock therapy can be a potential therapeutic approach to eradicate the intraluminal Candida biofilms; however, there is no approved lock strategy against fungal species so far. The results of this study provide valuable evidence that nikkomycin Z acts synergistically in combination with caspofungin or micafungin against biofilms. In addition, this synergy was more pronounced for micafungin combined with nikkomycin Z. Therefore, nikkomycin Z can be considered as a potential agent in antifungal lock therapy especially with micafungin against C. albicans or C. parapsilosis biofilms.